The recommendation from Glass Lewis is a boost for Icahn’s plan to force change at the DNA sequencer, as he and Illumina’s management battle for proxies ahead of a shareholder vote on May 25.
Icahn wins proxy firm nod to oust CEO from Illumina board Read More »
The Med-PaLM 2 has the ability to review X-rays and mammograms, write reports about images and respond to follow-up questions from caregivers.
The growth reflects “increased procedure volumes” and a “continued surge in demand” for NuVasive devices.
NuVasive grows sales in Q1, allaying concerns about impact of $3.1B Globus merger Read More »
The committee members urged the agency to move quickly to improve access to Perrigo’s contraception pill.
FDA advisers back over-the-counter use of birth control pill Read More »
Una investigación revela el verdadero alcance del legado genético de los neandertales en la población humana actual de América Latina. “Pensamos en los neandertales como en seres muy diferentes a nosotros. Desde el descubrimiento en Europa de los primeros f …
ADN neandertal en la población humana de América Latina Read More »
PharmaCyte Biotech, Inc. (Nasdaq: PMCB) (“PharmaCyte” or the “Company”) today announces a cash tender offer for up to 7,750,000 shares at $3.25 per share, less any applicable withholding taxes and without interest.
As insulin prices skyrocket, pharmas and PBMs faced pointed critique from the Senate HELP Committee, led by Sen. Bernie Sanders (I-VT).
Pharma, PBMs Blame Each Other Under Intense Scrutiny from Sanders’ Health Committee Read More »
Colchicine, a drug used to treat gout, saw a 16-fold price increase since the FDA changed its policy toward single-ingredient oral colchicine products, which had previously been available generically.
Gout Disease Control Suffered After FDA-Driven Price Hike: Study Read More »
Las erupciones estelares pueden hacer inhabitables a planetas en órbita a la estrella que las emite. ¿Podrían tener también la capacidad de propiciar las condiciones aptas para la vida en los mundos donde se dejan sentir sus efectos? ¿Las erupciones del Sol contrib …
Las erupciones solares, ¿el actor oculto en el inicio de la vida en la Tierra? Read More »
Carisma Therapeutics Inc. (Nasdaq: CARM) (“Carisma” or the “Company”), a clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today reported financial results for the first quarter ended March 31, 2023 and provided business highlights.
